Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Expanded Lung Cancer Claim For Lilly’s Cyramza Faces US FDA Scrutiny
Feb 25 2020
•
By
Sue Sutter
Lilly seeks to move Cyramza's metastatic non-small cell lung cancer indication into the first-line setting. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers